- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Face-to-face consultations
- Phone consultations
Last updated: 17 Apr 2020
- Upper GI
- Home chemotherapy
Dr Prantik Das completed basic medical training in the UK and awarded MRCP in 2009.He subsequently joined Clinical Oncology training programme in Northern Ireland deanery. During his training, he obtained a postgraduate diploma from the University of London in Oncology. After completion of his FRCR in 2013, he went for Proton Therapy Fellowship at University of Florida, USA. He is very interested in hypofractionated radiotherapy as a means to escalate radiation dose to tumours and improve outcomes for men with locally advanced prostate cancer. This radiotherapy can be optimally delivered with High Dose Rate brachytherapy or with Image Guided Stereotactic Ablative Radiotherapy (SABR).
Dr Das has been actively involved in various national and international clinical trials( STAMPEDE, SOURCE, CASSIOPE, POUT, ATLAS, AQUARIAS, PAZO2, KEYNOTE 811
PLATFORM, SCOPE 2, RADICALS, ACE,
STAR )as Principal investigator .
He is a first author of a number of publications in peer-reviewed journals and also worked as reviewer in international journal. He has also contributed as author of Pocket Guide to Human Tumors and Cancer by CRC press USA.
Areas of interest
Prostate, Kidney, bladder, penis, testicular cancer oesophageal, stomach cancer , pancreas, gall bladder, neuroendocrine cancer, small bowel , and lung cancer
Radiotherapy: MR linac , SBRT ,SPACE OAR ,3 D conformal radiotherapy, Intensity Modulated Radiotherapy(IMRT) along with IGRT
Immunotherapy, Chemotherapy, biological therapy and novel anticancer therapy
Current NHS consultant posts held
Consultant Clinical Oncologist, University Hospitals of Derby and Burton NHS Foundation Trust
Honorary Assistant Professor
University of Nottingham, School of Medicine
Assistant Clinical Director of Oncology
Prostate Cancer, Radiation Therapy, MR guided radiotherapy ,Pineal Parenchymal tumours, metastatic prostate cancer, proton therapy, hypofractionated radiotherapy, SABR, Brachytherapy
Dr Das is principal investigator (PI) in various national and international clinical trials: (STAMPEDE, SOURCE, CASSIOPE, POUT, ATLAS, AQUARIAS, PAZO2, KEYNOTE 811, PLATFORM, SCOPE 2, RADICALS, STAR). He is chief investigator (CI) for ACES study.
Dr Prantik Das MBBS, MRCP, FRCR was awarded the iWantGreatCare certificate of excellence in 2020 for delivering outstanding care.
Dr Prantik Das and Susan Feely: Patient Hero Award: The wife of one of our patients at the Royal Derby Hospital took the time to express their huge thanks to both Dr Prantik Das and Susan Feely for “being so good at [their] jobs” and helping her husband through his stage 4 cancer treatment.
(Additional) Languages spoken
- Hindi - Fluent
- Bengali - Fluent
Abiraterone acetate plus Prednisone/Prednisolone compared with Enzalutamide in metastatic castration resistant prostate cancer before or after chemotherapy: A retrospective study of real-world data (ACES)
Prantik Das1,2 | Sarah Taylor1 | James Price1 | Michael Jones1 | Cristina Martin-Fernandez3 | Akram Ali1 | Thangrarajh Mugunthan1 | Chandrani Mallik1 | Colin Ward1
BJUI Comapass March 2020
P Das, S Mckinstry , A Devadass ,B Herron,S Jonnada,J A Harney ,D S Conkey: Are we over treating Pineal Parenchyma Tumour with Intermediate Differentiation? Assessing the Role of Localised Radiation Therapy and Literature Review: Springerplus Neurology. 2016; 5: 26
Sarah, Lawless, Das Prantik, and Benson Gary. “Systemic Therapy In Acquired Haemophilia – A Single Institute Experience.” The Ulster Medical Journal 85.3 (2016): 187–192. Print.
El-Helali, A, Das, P, Jain, S, Mitchell, DM, Shum, L, Stewart, DP & O’Sullivan, JM 2014, ‘From trial to practice: The Northern Ireland cancer center experience with abiraterone acetate in men with metastatic castration resistant prostate cancer‘ Journal of Clinical Oncology, vol 32, no. 15 Suppl, e161
Das P, McCaffrey S, Harney J A, Conkey D S: Re-evaluating The Efficacy and Toxicity of Procarbazine, Lomustine and Vincristine (PCV) in Relapsed Glioblastoma in the Concurrent/Adjuvant Temozolamide Era : Journal of Cancer Prevention & Current
P Das, D Conjey, J Harney : Localised radiation therapy for pineal parenchymal tumour with intermediate differentiation :A single institute experience published in Neuro Oncology Journal 2014 16 (suppl 6): vi3 doi:10.1093/neuonc/nou249.13
Das P, Shum L, Mitchell D: Outcome of Abiraterone in metastatic prostate cancer: An audit to assess real life experience in Northern Ireland abstract publication in Clinical Oncology Volume 26, Supplement 1, June 2014.
Das P, McCarty H: The shape of soft tissue sarcoma services in Northern Ireland: An Audit to evaluate current practice abstract publication in Clinical Oncology Volume 26, Supplement 1, Page S5, June 2014.
Courses offered to GPs
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.https://www.iwantgreatcare.org/doctors/dr-prantik-das-mbbs-mrcp-frcr
- FRCR Royal College of Radiologist UK 2013
- MRCP Royal College of Physicians UK 2009
Reference number 6084584
Affiliations / memberships
Royal College of Radiologist UK
European Society off Medical Oncology
American Society of Clinical Oncology